Nicolas Escriou

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Coronavirus Disease

Endothelial Cells

Immune Response

Top Venues

Journal of virology

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jérémy Brunet, Zaineb Choucha, Marion Gransagne, Houda Tabbal, Min-Wen Ku, Julian Buchrieser, Priyanka Fernandes, Damien Batalie, Jodie Lopez, Laurence Ma, Evelyne Dufour, Emeline Simon, David Hardy, Stéphane Petres, Françoise Guinet, Helene Strick-Marchand, Marc Monot, Pierre Charneau, Laleh Majlessi, W Paul Duprex, Christiane Gerke, Annette Martin, Nicolas Escriou
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model. Journal of virology 98 (5) (2024)
Jérémy Brunet, Zaineb Choucha, Marion Gransagne, Houda Tabbal, Min-Wen Ku, Julian Buchrieser, Priyanka Fernandes, Damien Batalie, Jodie Lopez, Laurence Ma, Evelyne Dufour, Emeline Simon, David Hardy, Stéphane Petres, Françoise Guinet, Helene Strick-Marchand, Marc Monot, Pierre Charneau, Laleh Majlessi, W Paul Duprex, Christiane Gerke, Annette Martin, Nicolas Escriou
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model. Journal of virology 98 (5) (2024)
Sham Nambulli, Nicolas Escriou, Linda J Rennick, Matthew J Demers, Natasha L Tilston-Lunel, Anita K McElroy, Dominique J Barbeau, Nicholas A Crossland, Ryan M Hoehl, Sabrina Schrauf, Alexander G White, H Jacob Borish, Jaime A Tomko, Lonnie J Frye, Charles A Scanga, Joanne L Flynn, Annette Martin, Christiane Gerke, Amy L Hartman, W Paul Duprex
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease. Journal of virology 98 (5) (2024)
Sham Nambulli, Nicolas Escriou, Linda J Rennick, Matthew J Demers, Natasha L Tilston-Lunel, Anita K McElroy, Dominique J Barbeau, Nicholas A Crossland, Ryan M Hoehl, Sabrina Schrauf, Alexander G White, H Jacob Borish, Jaime A Tomko, Lonnie J Frye, Charles A Scanga, Joanne L Flynn, Annette Martin, Christiane Gerke, Amy L Hartman, W Paul Duprex
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease. Journal of virology 98 (5) (2024)
Jérémy Brunet, Zaineb Choucha, Marion Gransagne, Houda Tabbal, Min-Wen Ku, Julian Buchrieser, Priyanka Fernandes, Damien Batalie, Jodie Lopez, Laurence Ma, Evelyne Dufour, Emeline Simon, David Hardy, Stéphane Petres, Françoise Guinet, Helene Strick-Marchand, Marc Monot, Pierre Charneau, Laleh Majlessi, W Paul Duprex, Christiane Gerke, Annette Martin, Nicolas Escriou
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model. Journal of virology 98 (5) (2024)
Jérémy Brunet, Zaineb Choucha, Marion Gransagne, Houda Tabbal, Min-Wen Ku, Julian Buchrieser, Priyanka Fernandes, Damien Batalie, Jodie Lopez, Laurence Ma, Evelyne Dufour, Emeline Simon, David Hardy, Stéphane Petres, Françoise Guinet, Helene Strick-Marchand, Marc Monot, Pierre Charneau, Laleh Majlessi, W Paul Duprex, Christiane Gerke, Annette Martin, Nicolas Escriou
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model. Journal of virology (2024)
Sham Nambulli, Nicolas Escriou, Linda J Rennick, Matthew J Demers, Natasha L Tilston-Lunel, Anita K McElroy, Dominique J Barbeau, Nicholas A Crossland, Ryan M Hoehl, Sabrina Schrauf, Alexander G White, H Jacob Borish, Jaime A Tomko, Lonnie J Frye, Charles A Scanga, Joanne L Flynn, Annette Martin, Christiane Gerke, Amy L Hartman, W Paul Duprex
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease. Journal of virology 98 (5) (2024)
Sham Nambulli, Nicolas Escriou, Linda J Rennick, Matthew J Demers, Natasha L Tilston-Lunel, Anita K McElroy, Dominique J Barbeau, Nicholas A Crossland, Ryan M Hoehl, Sabrina Schrauf, Alexander G White, H Jacob Borish, Jaime A Tomko, Lonnie J Frye, Charles A Scanga, Joanne L Flynn, Annette Martin, Christiane Gerke, Amy L Hartman, W Paul Duprex
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease. Journal of virology (2024)
Jérémy Brunet, Zaineb Choucha, Marion Gransagne, Houda Tabbal, Min-Wen Ku, Julian Buchrieser, Priyanka Fernandes, Damien Batalie, Jodie Lopez, Laurence Ma, Evelyne Dufour, Emeline Simon, David Hardy, Stéphane Petres, Françoise Guinet, Helene Strick-Marchand, Marc Monot, Pierre Charneau, Laleh Majlessi, W Paul Duprex, Christiane Gerke, Annette Martin, Nicolas Escriou
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model. Journal of virology 98 (5) (2024)
Sham Nambulli, Nicolas Escriou, Linda J Rennick, Matthew J Demers, Natasha L Tilston-Lunel, Anita K McElroy, Dominique J Barbeau, Nicholas A Crossland, Ryan M Hoehl, Sabrina Schrauf, Alexander G White, H Jacob Borish, Jaime A Tomko, Lonnie J Frye, Charles A Scanga, Joanne L Flynn, Annette Martin, Christiane Gerke, Amy L Hartman, W Paul Duprex
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease. Journal of virology (2024)
Jérémy Brunet, Zaineb Choucha, Marion Gransagne, Houda Tabbal, Min-Wen Ku, Julian Buchrieser, Priyanka Fernandes, Damien Batalie, Jodie Lopez, Laurence Ma, Evelyne Dufour, Emeline Simon, David Hardy, Stéphane Petres, Françoise Guinet, Helene Strick-Marchand, Marc Monot, Pierre Charneau, Laleh Majlessi, W Paul Duprex, Christiane Gerke, Annette Martin, Nicolas Escriou
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model. Journal of virology 98 (5) (2024)
Sham Nambulli, Nicolas Escriou, Linda J Rennick, Matthew J Demers, Natasha L Tilston-Lunel, Anita K McElroy, Dominique J Barbeau, Nicholas A Crossland, Ryan M Hoehl, Sabrina Schrauf, Alexander G White, H Jacob Borish, Jaime A Tomko, Lonnie J Frye, Charles A Scanga, Joanne L Flynn, Annette Martin, Christiane Gerke, Amy L Hartman, W Paul Duprex
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease. Journal of virology 98 (5) (2024)
Jérémy Brunet, Zaineb Choucha, Marion Gransagne, Houda Tabbal, Min-Wen Ku, Julian Buchrieser, Priyanka Fernandes, Damien Batalie, Jodie Lopez, Laurence Ma, Evelyne Dufour, Emeline Simon, David Hardy, Stéphane Petres, Françoise Guinet, Helene Strick-Marchand, Marc Monot, Pierre Charneau, Laleh Majlessi, W Paul Duprex, Christiane Gerke, Annette Martin, Nicolas Escriou
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model. Journal of virology 98 (5) (2024)
Sham Nambulli, Nicolas Escriou, Linda J Rennick, Matthew J Demers, Natasha L Tilston-Lunel, Anita K McElroy, Dominique J Barbeau, Nicholas A Crossland, Ryan M Hoehl, Sabrina Schrauf, Alexander G White, H Jacob Borish, Jaime A Tomko, Lonnie J Frye, Charles A Scanga, Joanne L Flynn, Annette Martin, Christiane Gerke, Amy L Hartman, W Paul Duprex
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease. Journal of virology (2024)
Ludivine Grzelak, Sarah Temmam, Cyril Planchais, Caroline Demeret, Laura Tondeur, Christèle Huon, Florence Guivel-Benhassine, Isabelle Staropoli, Maxime Chazal, Jeremy Dufloo, Delphine Planas, Julian Buchrieser, Maaran Michael Rajah, Remy Robinot, Françoise Porrot, Mélanie Albert, Kuang-Yu Chen, Bernadette Crescenzo-Chaigne, Flora Donati, François Anna, Philippe Souque, Marion Gransagne, Jacques Bellalou, Mireille Nowakowski, Marija Backovic, Lila Bouadma, Lucie Le Fevre, Quentin Le Hingrat, Diane Descamps, Annabelle Pourbaix, Cédric Laouénan, Jade Ghosn, Yazdan Yazdanpanah, Camille Besombes, Nathalie Jolly, Sandrine Pellerin-Fernandes, Olivia Cheny, Marie-Noëlle Ungeheuer, Guillaume Mellon, Pascal Morel, Simon Rolland, Felix A Rey, Sylvie Behillil, Vincent Enouf, Audrey Lemaitre, Marie-Aude Créach, Stéphane Petres, Nicolas Escriou, Pierre Charneau, Arnaud Fontanet, Bruno Hoen, Timothee Bruel, Marc Eloit, Hugo Mouquet, Olivier Schwartz, Sylvie van der Werf
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations. Science translational medicine 12 (559) (2020)